TELA Bio (TELA) Operating Margin (2018 - 2026)
TELA Bio (TELA) recorded quarterly Operating Margin of 55.23% in Q1 2026, down 73.37% quarter-over-quarter from 31.86% in Q4 2025, and up 132.0% on a YoY basis from 23.81% in Q1 2025.
TELA Bio (TELA) Operating Margin (2018 - 2026) Analysis & Trends
TELA Bio's Operating Margin history runs 9 years deep, the most recent figure standing at 55.23% for Q1 2026.
- In Q1 2026, Operating Margin rose 132.0% year-over-year to 55.23%; the TTM figure through Mar 2026 stood at 41.84% (down 2271.0% YoY), while the FY2025 annual figure was 42.05%, down 3054.0% from the prior year.
- Operating Margin was 55.23% for Q1 2026 at TELA Bio, down from 31.86% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 100.76% in Q4 2024 to a low of 119.6% in Q1 2022.
- Historically, Operating Margin has averaged 56.75% across 5 years, with a median of 67.64% in 2023.
- The sharpest annual moves came in 2024 and 2025: Operating Margin soared 17300 bps in 2024, then tumbled 13262 bps in 2025.
- A 5-year view of Operating Margin shows it stood at 81.22% in 2022, then increased by 11 bps to 72.23% in 2023, then soared by 240 bps to 100.76% in 2024, then slumped by 132 bps to 31.86% in 2025, then sank by 73 bps to 55.23% in 2026.
- The last three Operating Margin figures came in at 55.23% (Q1 2026), 31.86% (Q4 2025), and 36.51% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.05% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 15.55% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 16.24% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 21.16% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 28.97% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 6.17% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 21.42% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 10.04% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.94% |
| 10 | TELA Bio | 48.23 Mn | 8.69 Mn | 12.52 Mn | -55.23% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -55.23% |
| Dec 31, 2025 | -31.86% |
| Sep 30, 2025 | -36.51% |
| Jun 30, 2025 | -44.96% |
| Mar 31, 2025 | -56.54% |
| Dec 31, 2024 | 100.76% |
| Sep 30, 2024 | -49.40% |
| Jun 30, 2024 | -71.90% |
| Mar 31, 2024 | -29.07% |
| Dec 31, 2023 | -72.23% |
| Sep 30, 2023 | -67.64% |
| Jun 30, 2023 | -71.49% |
| Mar 31, 2023 | -94.50% |
| Dec 31, 2022 | -81.22% |
| Sep 30, 2022 | -85.02% |
| Jun 30, 2022 | -98.38% |
| Mar 31, 2022 | -119.60% |
| Dec 31, 2021 | -91.40% |
| Sep 30, 2021 | -94.29% |
| Jun 30, 2021 | -96.73% |